The Structural Genomics Consortium at University College London (SGC-UCL) is led by Prof Matthew Todd. Mat’s laboratory has been dedicated to open science for many years, in particular how openness may be used to accelerate research and the discovery of new medicines for the public good.
The main SGC-UCL research programs include the Open Chemistry Networks (OCN) initiative which brings together synthetic chemists from around the world to work with the SGC’s expertise in biochemistry and biology to discover new bioactive small molecules (chemical probes) that can help us understand novel biology and hence find new treatments for disease. Anyone may contribute to OCN and all data is shared between participants.
GC-UCL is a core lab of READDI-AViDD and the Women’s Health Initiative.